WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Stock Ownership - Who owns Arrivent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrivent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robin LachapelleChief Operating Officer2024-09-1912,364$3.65
$45.13kBuy
Robin LachapelleChief Operating Officer2024-09-192,471$2.28
$5.63kBuy
Robin LachapelleChief Operating Officer2024-09-197,164$2.28
$16.33kBuy
Robin LachapelleChief Operating Officer2024-09-192,867$2.28
$6.54kBuy
Robin LachapelleChief Operating Officer2024-09-192,700$6.24
$16.85kBuy

1 of 1

AVBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVBP insiders and whales buy or sell their stock.

AVBP Shareholders

What type of owners hold Arrivent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hhlr Advisors Ltd13.11%4,484,672$91.17MInstitution
Hillhouse Investment Management Ltd13.11%4,484,672$91.17MInsider
Orbimed Advisors LLC8.85%3,027,328$61.55MInstitution
Suvretta Capital Management LLC6.83%2,337,496$47.52MInstitution
Blackrock Inc6.25%2,139,788$43.50MInstitution
Fmr LLC6.08%2,078,659$42.26MInstitution
Infinitum Asset Management LLC6.04%2,066,238$42.01MInstitution
Octagon Capital Advisors LP6.02%2,059,387$41.87MInstitution
Novo Holdings A5.47%1,872,142$38.06MInstitution
James Healy4.96%1,696,752$34.49MInsider

1 of 3

AVBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVBP73.48%26.52%Net Buying
IMTX75.16%0.00%
GYRE1.58%98.42%Net BuyingNet Selling
DAWN59.49%40.51%Net SellingNet Selling
EYPT27.22%72.78%Net SellingNet Selling
View Top Biotech Stocks

Arrivent Biopharma Stock Ownership FAQ

Who owns Arrivent Biopharma?

Arrivent Biopharma (NASDAQ: AVBP) is owned by 84.98% institutional shareholders, 30.68% Arrivent Biopharma insiders, and 0.00% retail investors. Hillhouse Investment Management Ltd is the largest individual Arrivent Biopharma shareholder, owning 4.48M shares representing 13.11% of the company. Hillhouse Investment Management Ltd's Arrivent Biopharma shares are currently valued at $95.70M.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.